Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Cannabidiol, FAAH, and Affective Orofacial Pain
2026-10-01
A 2026 Brain Research Bulletin study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive abnormalities in mice. Its experiments connect peripheral CB2-linked anti-inflammatory effects, central CB1-associated endocannabinoid changes, and normalization of serotonin activity in the central amygdala, providing a multidimensional framework for pain research.
-
Regorafenib: From Kinase Breadth to RRM2 Biology
2026-09-30
Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase tool: emerging melanoma data connect its multikinase activity to RRM2 reduction and ERK/E2F3 signaling. This thought-leadership guide translates that mechanistic insight into practical strategies for angiogenesis research, cancer biology research, and translational oncology workflows.
-
Carbapenemase Transmission in Guangdong CREC
2026-09-30
Chen and colleagues integrated carbapenemase gene detection, plasmid localization, conjugation testing, antimicrobial susceptibility profiling, mobile-element analysis, and ERIC-PCR to investigate carbapenem-resistant Enterobacter cloacae across eight teaching hospitals. The study identifies plasmid-associated blaNDM-1, extensive horizontal transfer potential, and hospital-spanning genotypes as important priorities for resistance surveillance and infection-control research.
-
Neomycin sulfate for RNA/DNA Research Workflows
2026-09-29
Neomycin sulfate is an aminoglycoside antibiotic that functions as a versatile probe for RNA folding, DNA triplex stabilization, viral RNA recognition, and ion-channel gating. This workflow-focused guide shows how to build concentration screens, connect molecular readouts with microbiome and immune assays, and troubleshoot solubility, specificity, and experimental-design risks.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-09-29
The 2024 ACS Applied Materials & Interfaces study shows that lithium enhances BMSC osteogenesis by increasing Rab11a-associated exosomal Wnt10a secretion and activating the Wnt/β-catenin signaling pathway. Its comparison of lithium-engineered exosomes and GelMA hydrogels provides a mechanistic and materials-based framework for developing cell-free strategies for bone repair.
-
Laminin (925-933) for ECM Assays
2026-09-28
Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-mediated adhesion from the structural complexity of full-length laminin. This guide translates its validated attachment and chemotaxis behavior into practical 2D assays and carefully bounded exploratory workflows for ECM-supported islet organoid research.
-
Dhx9 Shapes TH17 Differentiation and Autoimmunity
2026-09-28
Su et al. identify the nuclear helicase Dhx9 as a chromatin-level regulator that helps establish the TH17 transcriptional program, linking IL-6–STAT3 signaling to accessibility and transcription-factor binding at Rorc and Il17. T-cell-specific Dhx9 deletion reduced TH17 differentiation and autoimmune disease severity in mouse models, while punicalagin provided preliminary pharmacological evidence for targeting this pathway.
-
Cisplatin Workflows for Cancer Research
2026-09-27
Build reliable Cisplatin experiments around fresh preparation, matched vehicle controls, and readouts that connect DNA damage with cell fate. A resistance-focused lung cancer study also offers a useful framework for comparing free drug with enzyme-responsive, shRNA-enabled delivery—without confusing a delivery platform with the compound itself.
-
PYR-41 as a Probe of Ubiquitin-Dependent Signaling
2026-09-26
PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, can help researchers test how ubiquitin activation shapes inflammatory signaling and protein stability. This article connects its strengths and limitations to recent findings on CD40–STING signaling in esophageal cancer, with practical guidance for designing interpretable experiments.
-
Ampicillin Sodium: Assays, Workflows & Troubleshooting
2026-09-25
Build more interpretable antibacterial activity assays with Ampicillin sodium as a mechanistic probe and comparator—not as a substitute for strain-specific validation. This guide connects a classic β-lactam comparison study to practical dilution workflows, controls, and troubleshooting decisions.
-
NVP-BGJ398 Phosphate: Interpreting FGFR3 Rescue
2026-09-25
Explore how NVP-BGJ398 phosphate can help separate FGFR pathway engagement from phenotypic rescue in preclinical models. A close reading of mouse-model evidence highlights assay choices, inhibitor selectivity, and the limits of translating skeletal findings to cancer research.
-
Enhanced ECL Detection Kit for Protein Studies
2026-09-24
The ECL Chemiluminescent Substrate Detection Kit (Enhanced) is an HRP-based western blot chemiluminescence detection reagent designed for low-picogram protein detection. This article separates the kit’s reported performance and handling specifications from the biological findings on gingerenone A and renal cell carcinoma.
-
Ampicillin Sodium: From Target Biology to Translation
2026-09-24
A mechanistic and translational perspective on Ampicillin sodium, connecting transpeptidase inhibition to rigorous antibacterial assays, resistance-aware study design, and responsible interpretation of infection-model data.
-
DDI2–NFE2L1 Proteasome Adaptation Limits Ferroptosis
2026-09-23
The study identifies DDI2-mediated NFE2L1 processing as an adaptive response that helps maintain proteasome function during ferroptotic stress. Disrupting this pathway, including with nelfinavir in the reported cell experiments, weakens proteasomal activity and increases ferroptosis sensitivity, suggesting a potential route for experimental sensitization that requires further validation.
-
Geneticin, G-418 Sulfate: Cell Selection Guide
2026-09-23
Geneticin, G-418 Sulfate is a water-soluble aminoglycoside used to select cells expressing the neomycin resistance gene and to support defined antiviral assays. It should be titrated for each cell line and should not be used as a universal substitute for other selection antibiotics or as evidence of antiviral efficacy outside the tested Dengue virus serotype 2 BHK-cell context.